News

The milestone payment was triggered from the first patient enrollment in an open-label Phase 2 study to evaluate the safety and efficacy of MEK162 in patients with malignant

Eisai Brazil will establish an initial infrastructure to support its operations debut into the Brazilian market. Eisai New Markets and ASEAN president Hajime Shimizu said the establishment of

Sinclair IS Pharma will be headquartered in UK with direct distribution operations in the UK, France, Germany, Italy, Spain and Ireland and its own manufacturing and product development

The company has received the US Food and Drug Administration approval for Cuvposa in July 2010 on the basis of a Phase III study of 38 subjects which

Banner Pharmacaps is a specialty pharmaceutical company engaged in research, development, and manufacturing of gelatin-based dosage forms. Impax president and CEO Larry Hsu said in less than a

The new patent entitled, ‘Solid Ganaxolone formulations and methods for the making and use thereof,’ describes a novel class of small molecules to improve stability and bioavailability of

The first trail results showed that VB-111 was safe and specific and may offer additive effect to chemotherapy. In the trial, the researchers investigated the safety and efficacy

SIRO Clinpharm, a global clinical research organizations (CRO), offers full scope services, conducting clinical trials in the pharmaceutical, biotechnology and medical devices sectors. The company has offices in

The study of AVL-292-001 was a double-blind, placebo-controlled, single ascending dose study in healthy volunteers and in this study AVL-292 demonstrated favorable safety, tolerability and pharmacokinetics. In addition,